phenyl acetate has been researched along with Non-alcoholic Fatty Liver Disease in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 15 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, R; Clarke, JM; Hase, K; Hattori, K; Ito, M; Kamikado, K; Kanai, T; Kim, YG; Kimura, I; Nakamoto, N; Onuki, M; Yamada, T | 1 |
| Dhingra, S; Mahadik, JD; May, SB; Tarabishy, Y; Vierling, JM | 1 |
| Bates, J; Breckenridge, DG; Hollenback, D; Kusam, S; Mahadevan, S; Marchand, B; Okesli-Armlovich, A; Olson, I; Seung, M; Toteva, M; Trevaskis, JL; Vijayakumar, A; Wang, T | 1 |
| Heo, SJ; Im, ST; Kang, H; Kim, WC; Lee, SH; Mun, H; Park, S | 1 |
| Ding, Y; Ho-Kwan Cheung, A; Ji, F; Liang, W; Liu, W; Song, Q; Wei, H; Wong, N; Yu, J; Zhang, X; Zhou, Y | 1 |
| Zucchi, R | 1 |
| Chen, L; Deng, M; Ge, S; Guo, H; Liu, C; Qu, F; Ren, F; Wu, C; Zhang, H; Zhang, M; Zhao, L | 1 |
| Abbott, SD; Blais, A; Cloutier, MP; Corpuz, R; Duceppe, JS; Felton, A; Gagnon, L; Gagnon, W; Geerts, L; Gervais, L; Grouix, B; Hébert, RL; Hince, K; Kennedy, CRJ; Laplante, SR; Laurin, P; Laverdure, A; Leblond, FA; Leduc, M; Letourneau, S; Ouboudinar, J; Quintela, VM; Sarra-Bournet, F; Simard, JC; Thibodeau, JF; Tremblay, M; Zacharie, B | 1 |
| Hwang, SJ; Im, HJ; Kang, JY; Lee, JS; Lee, SB; Son, CG | 1 |
| Sunami, Y | 1 |
| He, LB; Huang, L; Li, N; Li, TT; Sun, YR; Tang, L; Wang, TY | 1 |
| Beigelman, LN; Blatt, LM; Chanda, S; Deval, J; Gupta, K; Jekle, A; Lin, TI; Luong, XG; McGowan, D; Misner, D; Mukherjee, S; Raboisson, P; Stevens, SK; Stoycheva, A; Symons, JA; Vandyck, K; Williams, C | 1 |
| Abdullah, N; Aminudin, N; Teoh, HL | 1 |
| Anton, M; Bayerl, F; Billeter, AT; Boettler, T; Böttcher, JP; Bowman, A; Donakonda, S; Dudek, M; Dufour, JF; Effenberger, M; Filpe, P; Garcia-Caceres, C; Gruber, T; Guillot, A; Haller, D; Hartmann, D; Heeren, R; Hegenbarth, S; Heide, D; Heikenwälder, M; Hüser, N; Inverso, D; Kabat, AM; Käser, R; Knolle, PA; Koch-Nolte, F; Laschinger, M; Leone, V; Mallm, JP; Meiser, P; Müller, F; Müller-Stich, B; Murray, PJ; Öllinger, R; Pearce, EJ; Pfister, D; Rad, R; Ramadori, P; Reider, S; Roth, S; Schneider, A; Sebode, M; Seifert, G; Tacke, F; Thimme, R; Tilg, H; Wigger, J; Zehn, D | 1 |
| Abdallah, MS; Eldeen, AH; Mostafa, TM; Tantawy, SS | 1 |
| Chiellini, G; Columbano, A; Kowalik, MA | 1 |
| Baxter, J; Beddow, SA; Bogan, JS; Erion, DM; Grover, GJ; Kumashiro, N; Liao, XH; Phillips, KJ; Samuel, VT; Shulman, GI; Vatner, DF; Webb, P; Weismann, D; Weiss, RE | 1 |
| Chew, GT; Sahebkar, A; Watts, GF | 1 |
| Cimini, SL; Lin, JZ; Martagón, AJ; Phillips, KJ; Webb, P | 1 |
| Chang, KT; Choo, YK; Kim, JS; Kwak, DH | 1 |
4 review(s) available for phenyl acetate and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Thyroid Hormone Analogues: An Update.
Topics: Acetates; Anilides; Animals; Central Nervous System Diseases; Clinical Trials as Topic; Diiodothyronines; Drug Design; Dyslipidemias; Humans; Liver Diseases; Male; Mice; Mutation; Non-alcoholic Fatty Liver Disease; Phenols; Pyridazines; Rats; Signal Transduction; Thyroid Hormone Receptors alpha; Thyroid Hormone Receptors beta; Thyroid Hormones; Thyronines; Triiodothyronine; Uracil | 2020 |
NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling.
Topics: Acetates; Acetyl Coenzyme A; Acyltransferases; Carcinoma, Hepatocellular; Clinical Trials as Topic; Fatty Acid Desaturases; Fatty Acids; Fibrosis; Glutamine; Humans; Lipid Metabolism; Lipids; Liver Neoplasms; Metabolic Networks and Pathways; Non-alcoholic Fatty Liver Disease; Signal Transduction; Sterol Regulatory Element Binding Proteins | 2020 |
GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.
Topics: Acetates; Animals; Carcinoma, Hepatocellular; Cell Proliferation; Hepatocytes; Humans; Liver Diseases; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Phenols; Thyroid Hormone Receptors beta | 2017 |
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.
Topics: Acetates; Animals; Atherosclerosis; Chalcones; Cholesterol, HDL; Dyslipidemias; Fatty Liver; Fenofibrate; Humans; Insulin Resistance; Lipoproteins, HDL; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Propionates; Quinolines; Sulfonamides; Thiazoles; Triazoles; Triglycerides | 2014 |
1 trial(s) available for phenyl acetate and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
The leukotriene receptor antagonist montelukast in the treatment of non-alcoholic steatohepatitis: A proof-of-concept, randomized, double-blind, placebo-controlled trial.
Topics: Acetates; Adult; Biomarkers; Cyclopropanes; Double-Blind Method; Elasticity Imaging Techniques; Female; Humans; Leukotriene Antagonists; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Placebos; Proof of Concept Study; Prospective Studies; Quinolines; Sulfides; Treatment Outcome | 2021 |
15 other study(ies) available for phenyl acetate and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Commensal microbe-derived acetate suppresses NAFLD/NASH development via hepatic FFAR2 signalling in mice.
Topics: Acetates; Animals; Bacteroides; Clostridiales; Mice; Non-alcoholic Fatty Liver Disease; Receptors, G-Protein-Coupled | 2021 |
Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis.
Topics: Acetates; Adolescent; Adult; Aged; Alkaline Phosphatase; Biopsy; Female; Fibrosis; Hepatitis; Humans; Inflammation; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Plasma Cells; PPAR delta; Prevalence; Young Adult | 2022 |
Combinations of an acetyl CoA carboxylase inhibitor with hepatic lipid modulating agents do not augment antifibrotic efficacy in preclinical models of NASH and fibrosis.
Topics: Acetates; Acetyl-CoA Carboxylase; Animals; Fenofibrate; Humans; Hypertriglyceridemia; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; PPAR alpha; Rats; Triglycerides | 2022 |
Ishige okamurae Celluclast extract ameliorates non-alcoholic fatty liver in high-fructose diet-fed mice by modulation of lipid metabolism and gut microbiota composition.
Topics: Acetates; Animals; Diet; Diet, High-Fat; Fructose; Gastrointestinal Microbiome; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2023 |
Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
Topics: Acetates; Animals; Carcinoma, Hepatocellular; Diet, High-Fat; Disease Models, Animal; Humans; Interleukin-6; Liver; Liver Neoplasms; Mice; Microbiota; Non-alcoholic Fatty Liver Disease | 2023 |
SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD.
Topics: Acetates; Alanine Transaminase; Animals; Aspartate Aminotransferases; Butyrates; Butyric Acid; Fatty Acids, Volatile; Fatty Liver; Hepatocytes; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Propionates; Sodium Acetate | 2020 |
Fatty acid mimetic PBI-4547 restores metabolic homeostasis via GPR84 in mice with non-alcoholic fatty liver disease.
Topics: Acetates; Animals; Binding, Competitive; Biosensing Techniques; Cholesterol; Disease Models, Animal; Disease Progression; Drug Discovery; Fatty Acids; Female; Glucose; Glucose Tolerance Test; HEK293 Cells; Homeostasis; Humans; Ligands; Magnetic Resonance Spectroscopy; Male; Metabolomics; Mice; Mitochondria; Non-alcoholic Fatty Liver Disease; Obesity; Oxygen; Plasmids; Protein Binding; Receptors, G-Protein-Coupled | 2020 |
Ethyl Acetate Fraction of
Topics: Acetates; Amomum; AMP-Activated Protein Kinases; Animals; Diacylglycerol O-Acyltransferase; Diet, High-Fat; Disease Models, Animal; Lipid Metabolism; Lipids; Lipolysis; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; PPAR alpha; Sterol Regulatory Element Binding Protein 1 | 2020 |
Amelioration by
Topics: Acetates; Antioxidants; Biomarkers; Cell Survival; Cytokines; Flavonoids; Gene Expression Regulation; Hep G2 Cells; Humans; Inflammation Mediators; Lipid Metabolism; Lipogenesis; Non-alcoholic Fatty Liver Disease; Oleic Acid; Oxidative Stress; Phenols; Plant Extracts; RNA, Messenger; Salicaceae; Triglycerides | 2020 |
Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
Topics: Acetates; Angiopoietin-Like Protein 4; Animals; Cell Line, Tumor; Cholesterol, LDL; Diet, High-Fat; Disease Models, Animal; Drug Evaluation, Preclinical; Hepatocytes; Humans; Iodide Peroxidase; Liver; Malate Dehydrogenase; Male; Non-alcoholic Fatty Liver Disease; Organophosphonates; Phenols; Primary Cell Culture; Pyridazines; Rats; Thyroid Hormone Receptors beta; Transcription, Genetic; Uracil | 2020 |
In Vitro Antioxidation, Antihepatic Steatosis, and Anti-Inflammatory Effects of Ethyl Acetate Fraction from Auricularia nigricans (Agaricomycetes).
Topics: Acetates; Anti-Inflammatory Agents; Antioxidants; Auricularia; Humans; Non-alcoholic Fatty Liver Disease | 2021 |
Auto-aggressive CXCR6
Topics: Acetates; Animals; CD8-Positive T-Lymphocytes; Cell Death; Diet, High-Fat; Disease Models, Animal; Humans; Interleukin-15; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Receptors, CXCR6 | 2021 |
Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways.
Topics: Acetates; Anilides; Animals; Dietary Fats; Fatty Liver; Gene Expression; Gluconeogenesis; Glucose Transporter Type 4; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Male; Muscle, Skeletal; Non-alcoholic Fatty Liver Disease; Phenols; Rats; Rats, Sprague-Dawley; Signal Transduction; Thyroid Hormone Receptors beta; Triglycerides | 2013 |
The amelioration of hepatic steatosis by thyroid hormone receptor agonists is insufficient to restore insulin sensitivity in ob/ob mice.
Topics: Acetates; Anilides; Animals; Blood Glucose; Body Temperature; Dose-Response Relationship, Drug; Enzyme Induction; Glucose-6-Phosphatase; Insulin Resistance; Male; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Phenols; Receptors, Thyroid Hormone; Time Factors | 2015 |
Aristolochia manshuriensis Kom ethyl acetate extract protects against high-fat diet-induced non-alcoholic steatohepatitis by regulating kinase phosphorylation in mouse.
Topics: Acetates; Animals; Aristolochia; Diet, High-Fat; Extracellular Signal-Regulated MAP Kinases; JNK Mitogen-Activated Protein Kinases; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phosphorylation; Plant Extracts | 2016 |